The Division of Behavioral Health Services and Policy Research, headed by Lisa Dixon, MD, MPH, is charged with developing public-academic partnerships between researchers in Psychiatry and policy makers at OMH and elsewhere.
Research in the Division of Behavioral Medicine aims to understand the contribution of psychological, psychosocial, and behavioral factors to the onset, progression, and management of physical and mental disease...
The Division of Biostatistics and Data Coordination serves both as a research unit, and as a support unit, in the Department of Psychiatry at Columbia University and the New York State Psychiatric Institute (NYSPI).
Research is focused on developing a better understanding of the underlying mechanism of child and adolescent psychiatric disorders and developing effective assessment tools and interventions.
Primary research in the division focus on identification of risk factors for the occurrence and chronic course of mental and substance use disorders, developing and testing interventions to improve outcomes, and advancing work on diagnostic and other assessment procedures.
The Division of Clinical Therapeutics focuses on clinical research of non-psychotic psychiatric disorders on adults.
Using behavioral, cognitive and neurophysiological techniques, we investigate brain-behavior relationships and neurobiological and cognitive mechanisms underlying psychiatric disorders. Our work spans basic and preclinical studies, development and application of laboratory-based assessment, clinical trials and clinical care.
The Department of Developmental Neuroscience was established at NYSPI in 1984.
The mission of this division is to reduce the burden of psychiatric disorders through research, education, and service.
This department investigates the natural history of involvement in drugs, the risk factors and consequences of drug abuse in a lifespan perspective...
The Brain Stimulation and Therapeutic Modulation (BSTM) Division specializes in the use of emerging electromagnetic means of modulating brain function to study brain behavior relationships and to study and treat psychiatric and neurological disorders.
Formerly known as the Division of HIV, the Division of Gender, Sexuality and Health was expanded and renamed in 2012 to reflect the full scope of its research studies, educational initiatives, and expertise of its investigators.
The Division of Geriatric Psychiatry was formed in early 2007 after the former Department of Biological Psychiatry was split into the Division of Geriatric Psychiatry and the Division of Brain Stimulation.
The Division of Integrative Neuroscience is a research division aimed at understanding the pathophysiology underlying psychiatric illnesses using approaches that span multiple levels of neurobiological analysis.
The Law, Ethics and Psychiatry Division undertakes education and research on issues related to the impact of law and ethics on psychiatry, and on medicine more broadly, and on the role of psychiatry in the legal and correctional systems.
The Molecular Imaging and Neuropathology Division conducts studies to better understand abnormalities in persons suffering from a variety of brain disorders using state of the art imaging and clinical studies.
Research in the newly created Division of Molecular Therapeutics focuses on understanding molecular and cellular processes that underlie behavior, with an emphasis on existing or novel targets for therapeutic intervention in psychiatric disorders.
The Division of Neurobiology and Behavior consists of seventeen independent basic research laboratories in the Kolb Research Annex.
The Department of Psychiatric and Medical Genetics, with several research subdivisions, continues its long-standing goals of elucidating the genetic liability and mechanisms underlying psychiatric disorders and other behavioral anomalies.
The Department of Social Psychiatry has developed and sustains a program of research on important substantive and methodological issues in psychiatric epidemiology.
Research in this division focuses on antecedents and consequences of substance use and abuse, with particular emphasis on the development and testing of novel approaches to the treatment of substance abuse.
The area of research of the Division of Translational Imaging (DTI) at NYSPI is the development of novel tools and techniques to study neurotransmission in the living human brain...